Medical Countermeasures DARPA Selects Teams to Develop Vaccine Durability Prediction Model by Global Biodefense Staff January 13, 2023
Industry News Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding by Global Biodefense Staff January 12, 2023
Infectious Diseases How Are Bivalent COVID Vaccines Stacking Up Against Omicron? by Global Biodefense Staff January 12, 2023
Medical Countermeasures NISTCHO: New Living Reference Material for Producing Monoclonal Antibodies by Global Biodefense Staff January 12, 2023
CBRNE Protection from Biothreats: DOD to Modernize Medical Countermeasures Development by Global Biodefense Staff January 10, 2023
Industry News DoD Awards ENA Respiratory $4.38M for Broad-Spectrum Antiviral Development by Global Biodefense Staff January 10, 2023
Medical Countermeasures How Organ-on-a-chip Models Could Grease the Drug Development Pipeline by Global Biodefense Staff January 10, 2023
Medical Countermeasures Texas Biomed at Forefront of Sudan ebolavirus Vaccine Development by Global Biodefense Staff December 27, 2022
Medical Countermeasures NIH Grant Will Expand National Swine Resource and Research Center by Global Biodefense Staff October 25, 2022
Medical Countermeasures Study: Cash Incentives and Lotteries Do Little to Increase Adult Vaccinations by Global Biodefense Staff October 25, 2022
Medical Countermeasures Stem Cell Research Gives New Clues on Ebola Virus Damage to Organs by Global Biodefense Staff September 9, 2022
Medical Countermeasures NIH Begins Clinical Trial of Intradermal Monkeypox Vaccine Delivery to Expand Supply by Global Biodefense Staff September 8, 2022
Industry News Bavarian Nordic to Supply Additional Monkeypox Vaccine to EU Member States by Global Biodefense Staff September 7, 2022
Industry News Arcturus Awarded $63.2M to Advance Self-amplifying mRNA Vaccine for Pandemic Influenza Response by Global Biodefense Staff August 31, 2022
Medical Countermeasures New Universal Flu Vaccine Offers Broad Protection Against Influenza A Virus Infections by Global Biodefense Staff July 17, 2022
Medical Countermeasures Adverse Events After Simultaneous COVID-19 mRNA Booster, Flu Vaccination by Global Biodefense Staff July 16, 2022
Medical Countermeasures US Starts Clinical Trial for mRNA Nipah Virus Vaccine by Global Biodefense Staff July 11, 2022
Medical Countermeasures Targeting Poxviruses with Messenger RNA Technology by Global Biodefense Staff July 11, 2022
Medical Countermeasures US Begins Phase 1 Clinical Trial of Universal Flu Vaccine by Global Biodefense Staff June 28, 2022
Medical Countermeasures UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control by Global Biodefense Staff June 21, 2022
